Orla Hardiman, prof.

Professor Orla Hardiman (BSc, MB BCh BAO, MD) has been a Consultant Neurologist in Beaumont Hospital since 1996. She joined the academic faculty of Trinity College Dublin in 2013 as the first Professor of Neurology in modern times and was elected a Fellow of TCD in 2014.

Her research group comprises over 50 individuals working in neurodegeneration, with particular focus on ALS and frontotemporal dementia. She is author of over 500 peer reviewed publications She is author of over 500 peer reviewed publications in neurology, neuroscience neurogenetics, health services and health economics, with a h-index of 90 (Scopus) and over 33,700 citations.

She is a Principal Investigator in FutureNeuro and ADAPT Centres, and leads the SFI-funded PRECSION ALS. Prof. Hardiman is Co- Chair of ENCALS and TRICALS and is Editor-in-Chief of the journal Amyotrophic Lateral Sclerosis and the Frontotemporal Degenerations. She leads a clinical trial group for ALS and has participated as Principal Investigator in more than 30 clinical trials.

Prof. Hardiman is the recipient of a number of international awards including the American Academy of Neurology Palatucci Award for Advocacy (2002), the Sheila Essey Award in ALS Research (2009), the International ALS Alliance Forbes Norris Award (2011) and the Healey ALS Innovation Award (2020). In Ireland, she received the Tom Connor Distinguished Investigator Award (Irish Soc for Neuroscience 2021), the Trinity College Provost’s Innovation Award (2022), SFI Researcher of the Year Award (2022) and HRB Impact Award (2023). Her research is funded by Science Foundation Ireland, the Health Research Board, The American Centre for Disease Control, The American ALS Association, British MND Association, IMNDA, and RMN.